These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 33682983
1. Evaluating the effect of ursodeoxycholic acid on total bilirubin of neonates with glucose-6-phosphate dehydrogenase deficiency complicated by indirect hyperbilirubinaemia. Rezaie M, Gholami R, Jafari M, Haghighinejad H. J Paediatr Child Health; 2021 Aug; 57(8):1175-1181. PubMed ID: 33682983 [Abstract] [Full Text] [Related]
3. Evaluating the effects of different doses of ursodeoxycholic acid on neonatal jaundice. Gharehbaghi MM, Sani AM, Refeey M. Turk J Pediatr; 2020 May; 62(3):424-430. PubMed ID: 32558416 [Abstract] [Full Text] [Related]
4. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin. Valaes T, Drummond GS, Kappas A. Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434 [Abstract] [Full Text] [Related]
5. Effects of Two Different Doses of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates with Glucose-6-phosphate Dehydrogenase Deficiency Treated with Phototherapy: A Randomized Controlled Trial. Farhadi R, Keyhanian E, Naderisorki M, Nadi Ghara A. Glob Pediatr Health; 2023 May; 10():2333794X231156055. PubMed ID: 36814535 [Abstract] [Full Text] [Related]
6. Risk Factors Predicting the Need for Phototherapy in Glucose 6 Phosphate Dehydrogenase-Deficient Infants in a Large Retrospective Cohort Study. Gopagondanahalli KR, Mittal RA, Abdul Haium AA, Quek BH, Agarwal P, Daniel LM, Chua MC, Rajadurai VS. Neonatology; 2022 May; 119(4):494-500. PubMed ID: 35700699 [Abstract] [Full Text] [Related]
7. Co-inheritance of G6PD deficiency and 211 G to a variation of UGT1A1 in neonates with hyperbilirubinemia in eastern Guangdong. Xu JX, Lin F, Chen ZK, Luo ZY, Zhan XF, Wu JR, Ma YB, Li JD, Yang LY. BMC Pediatr; 2021 Dec 11; 21(1):564. PubMed ID: 34895177 [Abstract] [Full Text] [Related]
8. Rate of glucose-6-phosphate dehydrogenase deficiency in neonatal indirect hyperbilirubinemia at a private tertiary centre. Alhiwaishil HM, Alghareeb MA, Alkhars AS, Abdalla TH, Almohsen AA, Al Mutair A. Saudi Med J; 2024 Oct 11; 45(10):1057-1063. PubMed ID: 39379120 [Abstract] [Full Text] [Related]
9. Effect of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates Treated With Phototherapy. Honar N, Ghashghaei Saadi E, Saki F, Pishva N, Shakibazad N, Hosseini Teshnizi S. J Pediatr Gastroenterol Nutr; 2016 Jan 11; 62(1):97-100. PubMed ID: 26020375 [Abstract] [Full Text] [Related]
10. Efficacy of phototherapy in neonatal hyperbilirubinaemia associated with glucose-6-phosphate dehydrogenase deficient status. Tan KL, Boey KW. Eur J Pediatr; 1993 Jul 11; 152(7):601-4. PubMed ID: 8354322 [Abstract] [Full Text] [Related]
11. The effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy: a randomized clinical trial. Akefi R, Hashemi SM, Alinejad S, Almasi-Hashiani A. J Matern Fetal Neonatal Med; 2022 Nov 11; 35(21):4075-4080. PubMed ID: 33225772 [Abstract] [Full Text] [Related]
12. Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S, Kamali AA. Southeast Asian J Trop Med Public Health; 2008 May 11; 39(3):557-61. PubMed ID: 18564698 [Abstract] [Full Text] [Related]
13. Role of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a systematic review and meta-analysis of randomized controlled trials. Lazarus G, Francie J, Roeslani RD, Saldi SRF, Oswari H. Ital J Pediatr; 2022 Oct 17; 48(1):179. PubMed ID: 36253867 [Abstract] [Full Text] [Related]
14. Evaluation of neonatal indirect hyperbilirubinaemia at Zanjan Province of Iran in 2001-2003: prevalence of glucose-6-phosphate dehydrogenase deficiency. Koosha A, Rafizadeh B. Singapore Med J; 2007 May 17; 48(5):424-8. PubMed ID: 17453100 [Abstract] [Full Text] [Related]
15. Neonatal hyperbilirubinemia in infants with G6PD c.563C > T Variant. Moiz B, Nasir A, Khan SA, Kherani SA, Qadir M. BMC Pediatr; 2012 Aug 20; 12():126. PubMed ID: 22906047 [Abstract] [Full Text] [Related]
16. Identifying risk of neonatal hyperbilirubinaemia and early discharge for glucose-6-phosphate dehydrogenase deficient newborns in Singapore. Shah VA, Yeo CL. Ann Acad Med Singap; 2007 Dec 20; 36(12):1003-9. PubMed ID: 18185880 [Abstract] [Full Text] [Related]
17. Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy. Kaplan M, Abramov A. Pediatrics; 1992 Sep 20; 90(3):401-5. PubMed ID: 1518696 [Abstract] [Full Text] [Related]
18. Glucose-6-phosphate dehydrogenase deficiency in neonatal indirect hyperbilirubinemia. Atay E, Bozaykut A, Ipek IO. J Trop Pediatr; 2006 Feb 20; 52(1):56-8. PubMed ID: 15917260 [Abstract] [Full Text] [Related]
19. Evaluation of therapeutic effect of oral Ursodeoxycholic Acid on indirect hyperbilirubinemia in term neonates undergoing phototherapy: A randomized controlled clinical trial. Zarkesh M, Mahdipour S, Aghili S, Jafari A, Nouri SAH, Hassanzadeh Rad A, Ghalandari M, Tabrizi M. PLoS One; 2023 Feb 20; 18(12):e0273516. PubMed ID: 38085723 [Abstract] [Full Text] [Related]
20. Ursodeoxycholic acid as adjuvant treatment to phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis. Kuitunen I, Kiviranta P, Sankilampi U, Renko M. World J Pediatr; 2022 Sep 20; 18(9):589-597. PubMed ID: 35689782 [Abstract] [Full Text] [Related] Page: [Next] [New Search]